Antonella Del Corso
Via San Zeno 51
Pisa, 56123, Italy
Pisa, 56123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Metabolic Detoxification of Glucose and 4-Hydroxynonenal in Human Neuroblastoma Cell Models.
Journal: Antioxidants (Basel, Switzerland)
Published: January 07, 2026
An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid Derivatives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 23, 2025
Acute Hyperglycemia-Induced Inflammation in MIO-M1 Cells: The Role of Aldose Reductase.
Journal: International journal of molecular sciences
Published: June 21, 2025
Characterization of ADAMTS9 proteoglycanase activity: Comparison with ADAMTS1, ADAMTS4, and ADAMTS5.
Characterization of ADAMTS9 proteoglycanase activity: Comparison with ADAMTS1, ADAMTS4, and ADAMTS5.
Journal: The Journal of biological chemistry
Published: April 04, 2025
Response of a Human Lens Epithelial Cell Line to Hyperglycemic and Oxidative Stress: The Role of Aldose Reductase.
Journal: Antioxidants (Basel, Switzerland)
Published: February 15, 2023
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors.
Journal: European journal of medicinal chemistry
Published: January 30, 2023
Dissecting the Activity of Catechins as Incomplete Aldose Reductase Differential Inhibitors through Kinetic and Computational Approaches.
Journal: Biology
Published: August 08, 2022
In Search of Differential Inhibitors of Aldose Reductase.
Journal: Biomolecules
Published: February 07, 2022
Identifying Human PTP1B Enzyme Inhibitors from Marine Natural Products: Perspectives for Developing of Novel Insulin-Mimetic Drugs.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 21, 2022
Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.
Journal: Marine drugs
Published: July 30, 2021
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
Journal: Molecules (Basel, Switzerland)
Published: December 18, 2020
Last Updated: 09/26/2026